01.12.2011 | Letter to Editor
Switching to three pre-meal injections of insulin glulisine from the basal-bolus insulin therapy improves glycemic control in a patient with type 2 diabetes who had anti-insulin antibody
Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2011
Einloggen, um Zugang zu erhaltenExcerpt
Dear Sir, …Anzeige